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Background: There were few studies comparing the long-term outcomes of patients with diabetes mellitus (DM) and non-DM following 
endovascular therapy (EVT) for superficial femoral artery (SFA) diseases.
Methods: From 2004 to 2010, 337 consecutive patients underwent EVT for SFA. The clinical outcomes were compared between patients with DM 
(n=196) and those without DM (n=141). Major adverse cardio-cerebro vascular events (MACCE) were defined as death, any amputation, restenosis, 
any revascularization, ischemic cardiac/cerebro vascular events, and new onset of peripheral artery disease.
Results: Mean age was 71.8±7.6 years old. Mean follow-up period was 35.5±22.8 months. Time-to-event was shown as Kaplan-Meier curve in 
figure with log-rank test.
Conclusions: Although primary patency rate of DM-group was lower than that of non-DM-group, secondary patency rate was similar. DM-group was 
associated with higher frequency of MACCE.
 
